Literature DB >> 33257953

Evaluation of mediastinoscopy in mediastinal lymph node staging for non-small-cell lung cancer.

Ian Diebels1, Jeroen M H Hendriks1, Jan P Van Meerbeeck2, Patrick Lauwers1, Annelies Janssens2, Suresh K Yogeswaran1, Paul E Y Van Schil1.   

Abstract

OBJECTIVES: The purpose of this study was to assess the quality of video-assisted cervical mediastinoscopy (VACM) in the staging of non-small-cell lung cancer (NSCLC) at the Antwerp University Hospital with a focus on test effectiveness indicators, morbidity and unforeseen pN2 results.
METHODS: All consecutive VACM workups of cases of NSCLC performed between January 2010 and December 2015 were included to assess overall test quality and effectiveness. Quality assurance was performed in accordance with the recommendations of the European Society of Gastrointestinal Endoscopy and European Society of Thoracic Surgeons (ESTS) where appropriate.
RESULTS: A total of 168 video-assisted cervical mediastinoscopies were included. A total of 91.7% of the procedures were performed in accordance with the ESTS guideline. An unforeseen pN2 staging was identified in 10 anatomical lung resections (8.6%). Statistical analysis showed no significant association between VACM performed in accordance with the ESTS guideline and the presence of pN2 positive lymph nodes [χ2 (1) = 0.61; P = 0.57] and no association between VACM performed in accordance with the ESTS guideline and overall futile thoracotomy [χ2 (1) = 0.76; P = 0.50]. Calculations revealed a sensitivity of 81.8 [95% confidence interval (CI) 69.1-90.9], specificity of 100%, positive predictive value of 100%, negative predictive value of 91.9% (95% CI 86.6-95.2) and diagnostic accuracy of 94.1% (95% CI 89.33-97.11).
CONCLUSIONS: Overall, 91.7% of the VACM were performed in accordance with the ESTS guideline. This process resulted in a sensitivity of 81.8%, a negative predictive value of 91.9% and an unforeseen pN2 rate of 8.6%.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Endobronchial ultrasound; Endosonographic staging; Mediastinoscopy; Non-small-cell lung cancer; Preoperative staging; Transoesophageal ultrasound

Mesh:

Year:  2021        PMID: 33257953      PMCID: PMC8906709          DOI: 10.1093/icvts/ivaa263

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  27 in total

1.  Combined endobronchial and esophageal endosonography for the diagnosis and staging of lung cancer: European Society of Gastrointestinal Endoscopy (ESGE) Guideline, in cooperation with the European Respiratory Society (ERS) and the European Society of Thoracic Surgeons (ESTS).

Authors:  Peter Vilmann; Paul Frost Clementsen; Sara Colella; Mette Siemsen; Paul De Leyn; Jean-Marc Dumonceau; Felix J Herth; Alberto Larghi; Enrique Vazquez-Sequeiros; Enrique Vasquez-Sequeiros; Cesare Hassan; Laurence Crombag; Daniël A Korevaar; Lars Konge; Jouke T Annema
Journal:  Endoscopy       Date:  2015-06-01       Impact factor: 10.093

Review 2.  Combined endobronchial and endoscopic ultrasound-guided fine needle aspiration for mediastinal lymph node staging of lung cancer: a meta-analysis.

Authors:  Ruifeng Zhang; Kejing Ying; Liuhong Shi; Lianfeng Zhang; Lin Zhou
Journal:  Eur J Cancer       Date:  2013-03-05       Impact factor: 9.162

Review 3.  Endosonography Versus Mediastinoscopy in Mediastinal Staging of Lung Cancer: Systematic Review and Meta-Analysis.

Authors:  Inderpaul Singh Sehgal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Digambar Behera; Ritesh Agarwal
Journal:  Ann Thorac Surg       Date:  2016-11       Impact factor: 4.330

4.  Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?

Authors:  C M Sivrikoz; I Ak; F S Simsek; E Döner; E Dündar
Journal:  Thorac Cardiovasc Surg       Date:  2011-06-20       Impact factor: 1.827

5.  Video-assisted mediastinoscopy compared with conventional mediastinoscopy: are we doing better?

Authors:  Masaki Anraku; Ryo Miyata; Christopher Compeau; Yaron Shargall
Journal:  Ann Thorac Surg       Date:  2010-05       Impact factor: 4.330

6.  Endobronchial ultrasound versus mediastinoscopy for mediastinal nodal staging of non-small-cell lung cancer.

Authors:  Sang-Won Um; Hong Kwan Kim; Sin-Ho Jung; Joungho Han; Kyung Jong Lee; Hye Yun Park; Yong Soo Choi; Young Mog Shim; Myung-Ju Ahn; Keunchil Park; Yong Chan Ahn; Joon Young Choi; Kyung Soo Lee; Gee Young Suh; Man Pyo Chung; O Jung Kwon; Jhingook Kim; Hojoong Kim
Journal:  J Thorac Oncol       Date:  2015-02       Impact factor: 15.609

7.  Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer.

Authors:  Paul De Leyn; Christophe Dooms; Jaroslaw Kuzdzal; Didier Lardinois; Bernward Passlick; Ramon Rami-Porta; Akif Turna; Paul Van Schil; Frederico Venuta; David Waller; Walter Weder; Marcin Zielinski
Journal:  Eur J Cardiothorac Surg       Date:  2014-02-26       Impact factor: 4.191

Review 8.  Integrated PET/CT in the staging of nonsmall cell lung cancer: technical aspects and clinical integration.

Authors:  W De Wever; S Stroobants; J Coolen; J A Verschakelen
Journal:  Eur Respir J       Date:  2009-01       Impact factor: 16.671

9.  Phase III Study of Surgery Versus Definitive Concurrent Chemoradiotherapy Boost in Patients With Resectable Stage IIIA(N2) and Selected IIIB Non-Small-Cell Lung Cancer After Induction Chemotherapy and Concurrent Chemoradiotherapy (ESPATUE).

Authors:  Wilfried Ernst Erich Eberhardt; Christoph Pöttgen; Thomas Christoph Gauler; Godehard Friedel; Stefanie Veit; Vanessa Heinrich; Stefan Welter; Wilfried Budach; Werner Spengler; Martin Kimmich; Berthold Fischer; Heinz Schmidberger; Dirk De Ruysscher; Claus Belka; Sebastian Cordes; Rodrigo Hepp; Diana Lütke-Brintrup; Nils Lehmann; Martin Schuler; Karl-Heinz Jöckel; Georgios Stamatis; Martin Stuschke
Journal:  J Clin Oncol       Date:  2015-11-02       Impact factor: 44.544

10.  Long term survival of patients with unsuspected n2 disease in non-small cell lung cancer.

Authors:  Deok Heon Lee; Jae Bum Kim; Dong Yoon Keum; Ilseon Hwang; Chang Kwon Park
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2013-02-06
View more
  1 in total

1.  Positron emission tomography/computed tomography and endobronchial ultrasound-guided transbronchial needle aspiration to evaluate the status of N2 in preoperative non-small cell lung cancer: a diagnostic test.

Authors:  Shiwei Nie; Wencheng Yu; Xilin Hu; Hanlin Xu; Ruran Wen; Wenjie Jiao; Kaihua Tian
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.